Christina E. Hantsch, BS; Tonny Tanus, MD
Allergic bronchopulmonary aspergillosis, first described by Hinson and associates (1) in 1952, is a hypersensitivity reaction to the fungus Aspergillus. In patients with an underlying respiratory disorder such as asthma, the condition progresses to a fibrotic end stage unless it is detected early and treated aggressively with corticosteroids (2). The condition has been recognized more frequently in recent years, and the diagnosis is based on a combination of clinical, immunologic, and radiologic criteria (3). Characteristics of the condition include peripheral blood eosinophilia, immunologic reactivity to Aspergillus antigen, increased serum immunoglobulin E levels, central bronchiectasis, and pulmonary infiltrates. No cases of
Hantsch CE, Tanus T. Allergic Bronchopulmonary Aspergillosis with Adenopathy. Ann Intern Med. ;115:546–547. doi: 10.7326/0003-4819-115-7-546
Download citation file:
Published: Ann Intern Med. 1991;115(7):546-547.
Infectious Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use